Cargando…

Animal Models of Parkinson's Disease 2012

Detalles Bibliográficos
Autores principales:	Imai, Yuzuru, Venderova, Katerina, Lim, Kah-Leong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458279/ https://www.ncbi.nlm.nih.gov/pubmed/23029629 http://dx.doi.org/10.1155/2012/729428

Ejemplares similares

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Editorial for the Special Issue “Animal Models of Parkinson’s Disease and Related Disorders”
por: Imai, Yuzuru
Publicado: (2020)

Mycobacterial Diseases of Animals 2012
por: Palmer, Mitchell V., et al.
Publicado: (2012)

Animal Models of Human Pathology 2012
por: Fedele, Monica, et al.
Publicado: (2012)

Nutraceuticals in Parkinson’s Disease
por: Hang, Liting, et al.
Publicado: (2016)

Genetic Insights into Sporadic Parkinson's Disease Pathogenesis
por: Chai, Chou, et al.
Publicado: (2013)

Role of the ubiquitin proteasome system in Parkinson's disease
por: Lim, Kah-Leong, et al.
Publicado: (2007)

Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry
por: Lim, Kah-Leong, et al.
Publicado: (2013)

Mitochondrial homeostasis in Parkinson’s disease - a triumvirate rule?
por: Ng, Chee-Hoe, et al.
Publicado: (2017)

Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
por: Liu, Wei, et al.
Publicado: (2022)

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
por: Iseki, Tatou, et al.
Publicado: (2023)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

AF-6 Protects Against Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson’s Disease
por: Basil, Adeline H., et al.
Publicado: (2017)

Editorial: Molecular Links Between Mitochondrial Damage and Parkinson's Disease and Related Disorders
por: Imai, Yuzuru, et al.
Publicado: (2021)

Mitochondrial Dysfunction and Parkinson’s Disease—Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy
por: Foo, Aaron Song Chuan, et al.
Publicado: (2020)

The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson's Disease
por: Weng, Minrui, et al.
Publicado: (2018)

From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
por: Yeap, Yee Jie, et al.
Publicado: (2023)

Animal Models of Alzheimer's Disease
por: Casadesus, Gemma, et al.
Publicado: (2011)

Animal Models of Human Disease
por: Lange, Sigrun, et al.
Publicado: (2023)

Aminochrome as preclinical model for Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Animal Model for Prodromal Parkinson’s Disease
por: Taguchi, Tomoyuki, et al.
Publicado: (2020)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2
por: Angeles, Dario C., et al.
Publicado: (2016)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Animal Models of Diabetes and Metabolic Disease
por: Sasase, Tomohiko, et al.
Publicado: (2013)

Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Classic and New Animal Models of Parkinson's Disease
por: Blesa, Javier, et al.
Publicado: (2012)

International conference: Modeling & Design of Molecular Materials—MDMM 2012 (September 10–14, 2012, Wrocław, Poland)
por: Sokalski, W. Andrzej, et al.
Publicado: (2013)

Neurochemical changes in animal models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2013)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Aging, Physical Activity, and Disease Prevention 2012
por: Reuter, Iris
Publicado: (2012)

Animal Models of Diabetes and Metabolic Disease 2014
por: Sasase, Tomohiko, et al.
Publicado: (2015)

Animal Models of Diabetes and Related Metabolic Diseases
por: Sasase, Tomohiko, et al.
Publicado: (2019)

Animal Experimental Models in Bone Metabolic Disease
por: Usategui-Martín, Ricardo, et al.
Publicado: (2023)

Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson’s Disease Models by Alleviating Oxidative Stress
por: Wu, Yue, et al.
Publicado: (2023)

Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson’s disease
por: Imai, Yuzuru, et al.
Publicado: (2019)

Novel modeling methodologies for the neuropathological dimensions of Parkinson's disease
por: Vlamos, Panagiotis
Publicado: (2020)

Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
por: Imai, Yuzuru, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fd0j3f89rmij55k3r4kccomaam